RichardIanEnelowMD
Pulmonology • Lebanon, NHCritical Care Medicine, Pleural Disease
Professor, Medicine, Geisel School of Medicine
Dr. Enelow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Lebanon, NH 03756Phone+1 603-650-5533Fax+1 203-785-6414
Education & Training
University of Virginia Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1984 - 1986
Emory University School of MedicineInternship, Internal Medicine, 1983 - 1984
Boston University School of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1986 - Present
VT State Medical License 2021 - 2026
NH State Medical License 2007 - 2025
ME State Medical License 2020 - 2021
CT State Medical License 2003 - 2008
VA State Medical License 1988 - 2004- American Board of Internal Medicine Internal Medicine
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Pulmonary Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2007, 2009-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Top Doctors: New York Metro Area Castle Connolly, 2006-2008
- Join now to see all
Clinical Trials
- STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2012 Jul 16
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
- Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jul 30
- Join now to see all
Publications & Presentations
PubMed
- 46 citationsPseudomonas aeruginosa Cif Protein Enhances the Ubiquitination and Proteasomal Degradation of the Transporter Associated with Antigen Processing (TAP) and Reduces Majo...Jennifer M. Bomberger, Kenneth H. Ely, Naveen Bangia, Siying Ye, Kathy A. Green
The Journal of Biological Chemistry. 2014-01-03 - 25 citationsADAM17-mediated processing of TNF-α expressed by antiviral effector CD8+ T cells is required for severe T-cell-mediated lung injury.Matthew DeBerge, Kenneth H. Ely, Guang Shing Cheng, Richard I. Enelow
Plos One. 2013-11-06 - 280 citationsInfluenza A Inhibits Th17-Mediated Host Defense against Bacterial Pneumonia in MiceAnupa Kudva, Erich V. Scheller, Keven M. Robinson, Chris R. Crowe, Sun Mi Choi
Journal of Immunology. 2011-02-01
Grant Support
- Innate Regulation Of CD8+ T Cell Effector ActivitesNational Institute Of Allergy And Infectious Diseases2009–2011
- TNF Processing In Pulmonary ImmunopathologyNational Institute Of Allergy And Infectious Diseases2007–2011
- Type I Interferon Regulation Of Immunopathology In Influenza PneumoniaNational Center For Research Resources2010
- Type I Interferon Reulation Of Immunopathology In Influenza PneumoniaNational Center For Research Resources2008–2009
- Interferon-Gamma In Experimental Pulmonary FibrosisNational Heart, Lung, And Blood Institute2003–2005
- Mechanisms Of Cell-Mediated Lung InjuryNational Heart, Lung, And Blood Institute2003
- Interferon-Gamma In Experimental Pulmonary FibrosisNational Heart, Lung, And Blood Institute2002
- Mechanisms Of Cell-Mediated Lung InjuryNational Heart, Lung, And Blood Institute2000–2002
- Mechanisms Of T Cell Mediated Lung InjuryNational Heart, Lung, And Blood Institute1997–1999
- Antigen Processing In The LungNational Heart, Lung, And Blood Institute1992–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
